ACh precursors have been shown to prolong the favorable effects of acetylcholinesterase inhibitors on cognitive and behavioral improvements in patients with Alzheimer’s disease (AD) and mild to moderate vascular dementia (Adibhatla et al., 2005; Amenta et al., 2020). The gene discussed is ACHE; the disease is Alzheimer disease.